Latest Non Dilutive Funding News

Ceretas has completed the third milestone of its government-backed CUREator+ program, unlocking a final $692,578 non-dilutive funding tranche. The work delivered functional prototypes of proprietary neuronavigation software and a lift assist device intended to simplify operation of its next-generation Alzheimer’s ultrasound system.

EMVision has completed the first stage of a Melbourne Mobile Stroke Unit study, operating its portable brain scanner in homes, ambulances and a workplace. The small, non-diagnostic feasibility study produced strong usability results while pointing to a larger clinical validation step planned for next-generation units.

Raptor Metals has sold its remaining Australian Gold and Copper stake for approximately $468,200, converting a legacy asset into cash without issuing new shares. The proceeds add funding flexibility as the company advances copper exploration in New Brunswick.

Emyria has reported a sharp increase in FY26 revenue while expanding its psychedelic-assisted therapy network to five operational or announced clinics and 18 beds. Its first Sydney clinic is now fitted out and scheduled to begin treating patients in September, but utilisation and funding remain the next tests.

NoviqTech has secured a one-year extension on its $1.4 million unsecured loan facility, maintaining favourable terms to support its push for ASX reinstatement.

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.

Actinogen Medical reported a $15.38 million loss for FY2026 while progressing its lead Alzheimer's drug Xanamem toward pivotal trial results expected this November. The company secured regulatory alignment and strengthened its cash position to fund operations through mid-2027.

Ore Resources Ltd (ASX: OR3) has released a robust Scoping Study for its Kangaroo Hills Lithium Project, outlining a low-capital, fast-track Direct Shipping Ore (DSO) operation expected to generate substantial cash flow within a 16-month mine life.

Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.

Sinclair Gold has cleared a key drilling milestone at its Mt Henry project, prompting a $5 million cash payment to Westgold and cancelling over 7.5 million performance rights. The company also moves closer to completing a royalty deal with Stria Lithium, while preparing for a resource update by year-end.

EMVision Medical Devices has made significant strides in its emu™ bedside scanner pivotal trial and First Responder program, boosting FY26 revenue by 57% while trimming its net loss by 15%.

Latitude 66 has finalised the sale of its non-core Piastri Project to Capricorn Metals, converting the deal into approximately A$1.79 million in shares. Alongside a recent royalty portfolio sale, this boosts Latitude 66’s war chest with over A$5 million to fund core exploration in Finland and Western Australia.